BAIT
CDC7
CDC7L1, HsCDC7, Hsk1, huCDC7
cell division cycle 7
GO Process (12)
GO Function (4)
GO Component (5)
Gene Ontology Biological Process
- DNA replication [TAS]
- DNA replication initiation [IBA]
- G1/S transition of mitotic cell cycle [TAS]
- cell cycle phase transition [IMP]
- double-strand break repair via break-induced replication [IBA]
- mitotic cell cycle [TAS]
- peptidyl-serine phosphorylation [IBA]
- phagocytosis [IBA]
- positive regulation of G2/M transition of mitotic cell cycle [IMP]
- positive regulation of cell proliferation [IMP]
- positive regulation of nuclear cell cycle DNA replication [IMP]
- regulation of cell shape [IBA]
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
PREY
ING5
p28ING5
inhibitor of growth family, member 5
GO Process (8)
GO Function (2)
GO Component (3)
Gene Ontology Biological Process
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
Synthetic Lethality
A genetic interaction is inferred when mutations or deletions in separate genes, each of which alone causes a minimal phenotype, result in lethality when combined in the same cell under a given condition.
Publication
A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.
An emerging therapeutic strategy for cancer is to induce selective lethality in a tumor by exploiting interactions between its driving mutations and specific drug targets. Here we use a multi-species approach to develop a resource of synthetic lethal interactions relevant to cancer therapy. First, we screen in yeast ∼169,000 potential interactions among orthologs of human tumor suppressor genes (TSG) and ... [more]
Mol. Cell Aug. 04, 2016; 63(3);514-25 [Pubmed: 27453043]
Throughput
- High Throughput
Ontology Terms
- phenotype: growth abnormality (HP:0001507) [hela cell (BTO:0000567)]
Additional Notes
- Chemo-genetic screen with siRNAs
- Drug target: CDC7,CDK9 double mutant
- Drug: PHA-767491
- HeLa cervical cancer cell line
Curated By
- BioGRID